Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.

Item

http://www.wikidata.org/entity/Q43247710

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@en

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@nl

type

Item

label

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@en

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@nl

prefLabel

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@en

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@nl

P1476

Advent of novel phosphatidylch ...... roved gastrointestinal safety.

@en

P2093

Elizabeth J Dial

http://www.w3.org/2001/XMLSchema#string

Lenard M Lichtenberger

http://www.w3.org/2001/XMLSchema#string

Yun Jeong Lim

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin

The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action

Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited.

The anti-inflammatory drug indomethacin alters nanoclustering in synthetic and cell plasma membranes.

Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.

Oral phosphatidylcholine preserves the gastrointestinal mucosal barrier during LPS-induced inflammation.

Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently.

Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

P304

7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL.2013.7.1.7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235670133

http://www.w3.org/2001/XMLSchema#string

P698

23423874

http://www.w3.org/2001/XMLSchema#string

P921

phosphatidylcholines

P932

3572323

http://www.w3.org/2001/XMLSchema#string